NASDAQ:CDLX - Cardlytics Stock Price, Forecast & News

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

Cardlytics Inc (NASDAQ:CDLX) announced its quarterly earnings results on Tuesday, November, 12th. The company reported $0.03 EPS for the quarter, topping the Zacks' consensus estimate of ($0.28) by $0.31. The company earned $56.42 million during the quarter, compared to analysts' expectations of $50.02 million. Cardlytics's revenue for the quarter was up 63.2% on a year-over-year basis. During the same period last year, the firm earned ($0.15) earnings per share. View Cardlytics' Earnings History.

Cardlytics is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for Cardlytics.

Cardlytics issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $68.5-69.5 million, compared to the consensus revenue estimate of $59 million.

7 brokers have issued twelve-month price targets for Cardlytics' stock. Their forecasts range from $26.00 to $100.00. On average, they anticipate Cardlytics' stock price to reach $62.00 in the next twelve months. This suggests that the stock has a possible downside of 36.8%. View Analyst Price Targets for Cardlytics.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cardlytics.

Press coverage about CDLX stock has been trending neutral recently, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cardlytics earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Cardlytics.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Caterpillar (CAT), Alibaba Group (BABA), Trade Desk (TTD), Paycom Software (PAYC), Range Resources (RRC), Shopify (SHOP), Store Capital (STOR), Verizon Communications (VZ), Advanced Micro Devices (AMD) and NVIDIA (NVDA).

(CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Cardlytics' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (16.89%), CAS Investment Partners LLC (12.36%), Jennison Associates LLC (2.11%), Bank of New York Mellon Corp (1.93%), Bank of America Corp DE (1.69%) and Renaissance Technologies LLC (1.65%). Company insiders that own Cardlytics stock include Aimia Inc, Bryce Youngren, Clifford Sosin, David Leslie Adams, David Thomas Evans, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman. View Institutional Ownership Trends for Cardlytics.

CDLX stock was sold by a variety of institutional investors in the last quarter, including Polaris Venture Management Co. V L.L.C., Jennison Associates LLC, UBS Oconnor LLC, Penn Capital Management Co. Inc., Nicholas Investment Partners LP, New York State Common Retirement Fund, Goldman Sachs Group Inc. and PNC Financial Services Group Inc.. Company insiders that have sold Cardlytics company stock in the last year include Aimia Inc, Bryce Youngren, David Leslie Adams, David Thomas Evans, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman. View Insider Buying and Selling for Cardlytics.

CDLX stock was acquired by a variety of institutional investors in the last quarter, including CAS Investment Partners LLC, Bank of New York Mellon Corp, Victory Capital Management Inc., Renaissance Technologies LLC, Lord Abbett & CO. LLC, Victory Capital Management Inc., FMR LLC and Public Sector Pension Investment Board. View Insider Buying and Selling for Cardlytics.

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CDLX stock can currently be purchased for approximately $98.16.